HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 257 filers reported holding HAEMONETICS CORP in Q2 2019. The put-call ratio across all filers is 2.19 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $14,000 | -6.7% | 125 | 0.0% | 0.00% | 0.0% |
Q4 2020 | $15,000 | +36.4% | 125 | 0.0% | 0.00% | 0.0% |
Q3 2020 | $11,000 | 0.0% | 125 | 0.0% | 0.00% | 0.0% |
Q2 2020 | $11,000 | -8.3% | 125 | 0.0% | 0.00% | -50.0% |
Q1 2020 | $12,000 | -14.3% | 125 | 0.0% | 0.00% | 0.0% |
Q4 2019 | $14,000 | -12.5% | 125 | 0.0% | 0.00% | 0.0% |
Q3 2019 | $16,000 | +6.7% | 125 | 0.0% | 0.00% | 0.0% |
Q2 2019 | $15,000 | +36.4% | 125 | 0.0% | 0.00% | +100.0% |
Q1 2019 | $11,000 | -15.4% | 125 | 0.0% | 0.00% | -50.0% |
Q4 2018 | $13,000 | -7.1% | 125 | 0.0% | 0.00% | 0.0% |
Q3 2018 | $14,000 | +27.3% | 125 | 0.0% | 0.00% | 0.0% |
Q2 2018 | $11,000 | +22.2% | 125 | 0.0% | 0.00% | +100.0% |
Q1 2018 | $9,000 | -10.0% | 125 | -26.5% | 0.00% | 0.0% |
Q4 2017 | $10,000 | +25.0% | 170 | 0.0% | 0.00% | 0.0% |
Q3 2017 | $8,000 | +14.3% | 170 | 0.0% | 0.00% | 0.0% |
Q2 2017 | $7,000 | 0.0% | 170 | 0.0% | 0.00% | 0.0% |
Q1 2017 | $7,000 | – | 170 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Nitorum Capital, L.P. | 413,122 | $16,608,000 | 4.78% |
Altalis Capital Management LLC | 88,055 | $3,540,000 | 3.97% |
RUTABAGA CAPITAL MANAGEMENT LLC/MA | 513,619 | $20,647,000 | 3.54% |
Black Creek Investment Management Inc. | 1,118,613 | $44,968,000 | 3.46% |
HealthCor Management, L.P. | 1,150,000 | $46,230,000 | 2.61% |
Van Berkom & Associates Inc. | 1,136,971 | $45,706,000 | 1.83% |
AMERICAN CAPITAL MANAGEMENT INC | 567,896 | $22,829,000 | 1.77% |
FULLER & THALER ASSET MANAGEMENT, INC. | 2,062,539 | $82,914,000 | 1.25% |
Legato Capital Management LLC | 1,336 | $53,707,000 | 0.97% |
HEARTLAND ADVISORS INC | 351,314 | $14,123,000 | 0.78% |